利弗莫尔证券显示，亦诺微医药向港交所提交上市申请书，联席保荐人为花旗银行和中金公司。

Group 1 - The core point of the article is that Yinuo Medical has submitted a listing application to the Hong Kong Stock Exchange, with Citibank and CICC acting as joint sponsors [1] Group 2 - Yinuo Medical is seeking to go public, indicating potential growth and investment opportunities in the healthcare sector [1] - The involvement of major financial institutions like Citibank and CICC suggests strong backing and credibility for Yinuo Medical's listing efforts [1]